Session Description:

Aneurysmal subarachnoid haemorrhage (aSAH) is a rare, sudden, and life-threatening form of stroke accounting for 3% of all cardiovascular events. Secondary complications include rebleeding, cerebral vasospasm, cerebral infarction, and delayed cerebral ischaemia. In this interactive session co-chaired by Dr Randall Higashida and Dr Miki Fujimura, the expert Faculty will examine the burden of aSAH, the challenges of predicting and managing its consequences, and the promise of emerging treatments in this disease space. Dr Randall Higashida will open the symposium and will present evidence showing the clinical burden of aSAH. Dr Peter Vajkoczy and Dr Stephan Mayer will present patient case studies that demonstrate the hidden dangers of aSAH including challenges of diagnosis, management, and treatment. Dr Miki Fujimura and Dr Vajkoczy will examine the treatment landscape in aSAH in Japan, North America, and Europe, and discuss emerging therapies in these markets. Live polling will support audience interactivity with opportunities to engage with the expert Faculty throughout the symposium. The symposium will end with an all-Faculty Q&A and panel discussion. The symposium, sponsored by Idorsia, will take place on Thursday 27 October 2022 at 12:00–13:00 SGT, Summit 2, Suntec Singapore Convention & Exhibition Centre.